Skip to main navigation Skip to search Skip to main content

Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a single institution experience

  • Marc R. Matrana
  • , Tharakeswara Bathala
  • , Matthew T. Campbell
  • , Cihan Duran
  • , Aditya Shetty
  • , Purnima Teegavarapu
  • , Sarathi Kalra
  • , Lianchun Xiao
  • , Bradley Atkinson
  • , Paul Corn
  • , Eric Jonasch
  • , Nizar M. Tannir

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a single institution experience'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science